Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds

Banner Health

Status: Withdrawn

Conditions: Wounds

Treatments: Other: None available

Study type: Interventional

Funder types: Other

Identifiers

NCT00755989

morphine gel

Details and patient eligibility

About

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.

Full description

Patients will be randomized to receive either placebo (versa base gel) or morphine gel to wound. Patients receiving morphine gel will have a decrease in pain score and use less oral/intravenous pain medications.

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed and dated consent form & HIPAA
• >/= 18 yo
• Single stage 2-3 wound evaluated by our wound care team
• Alert and oriented (thinking ability clear and intact, physician approval)
• English language proficiency, likely to be able to participate in all scheduled evaluations

Exclusion criteria

• Allergy to morphine, codeine, or versa base
• pts taking medications for acute condition, other than for the wound pain (can be taking chronic pain meds if current dose stable for past 3 mo)
• Patients with neuropathies
• Patients with respiratory conditions
• Patients that are pregnant

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Double Blind

---

0 participants in 1 patient group

Arm Title 1

Other group

Description:

None available - study is no longer active.

Treatment:

Other: None available